ArticleJournal of neuro-oncology2024

Durable responses to trastuzumab deruxtecan in patients with leptomeningeal metastases from breast cancer with variable HER2 expression.

David Rogawski et al.PubMed ↗Publisher ↗

No numbers read from the abstract.